Joint Formulary & PAD

Ethinylestradiol with desogestrel - Contraception

You are here : Home > Formulary Search > Ethinylestradiol with desogestrel - Contraception

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Green
Formulations :
  • Tablets
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
Guidelines
SPC
Restrictions / Comments :
Important
Preferred

Preferred brands: Gedarel 20/150, Bimezza, Gedarel 30/150, Cimizt

 

Status 2

Non Formulary
Formulations :
  • Tablets
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
Guidelines
SPC
Restrictions / Comments :
Important

Mercilon, Marvilon - Not recommended for new initiations. Exisitng patients may remain on this brand.

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Ethinylestradiol with desogestrel
Indication :
Contraception
Group Name :
Keywords :
combined hormonal contraceptive, CHC
Brand Names Include :
Gedarel 20/150, Bimezza, Mercilon, Gedarel 30/150, Cimezt, Marvelon
Important Information :

NOTE - Trusts are unlikely to initiate oral contraceptives but will obtain supplies for the continuation of treatment during in-patient episodes.

Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Contraception
Supporting Documents :
0
Traffic Light Entries :
2

Committee Recommendations (1)

01 Jan 25 - Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

The Surrey Heartlands Area Prescribing Committee agreed the traffic light status of this drug and indication as part of the Joint Formulary review.

Other Indications

Below are listed other indications that Ethinylestradiol with desogestrel is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Contraception.